RTTNews | Jul 12, 2021 08:23AM EDT

08:22 Monday, July 12, 2021 (RTTNews.com) - Aditxt Inc. (ADTX) said that it has launched high-sensitivity neutralizing antibody test to detect individual immune response to COVID-19.

In Monday pre-market trading, ADTX was trading at $2.68 up $0.18 or 7.20%.

The company noted that AditxtScore for COVID-19, which was first introduced in August of 2020, differentiates itself from traditional antibody tests by delivering a detailed view of an individual's immune response to multiple antigens associated with the SARS-CoV-2 virus.

"Everyone's immune response is unique to that individual. We have been studying individual immune responses to COVID-19 and COVID-19 vaccination," said Amro Albanna, Co-founder and Chief Executive Officer of Aditxt.

AditxtScore for COVID-19 now includes virus-sSpecific infection blocking antibodies that assess the strength of an individual's immune response to SARS-CoV-2.

Read the original article on RTTNews ( https://www.rttnews.com/3208366/aditxt-launches-neutralizing-antibody-test-to-detect-individual-immune-response-to-covid-19.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved